Search results
Results From The WOW.Com Content Network
Medidata Solutions is an American technology company that develops and markets software as a service (SaaS) for clinical trials.These include protocol development, clinical site collaboration and management; randomization and trial supply management; capturing patient data through web forms, mobile health (mHealth) devices, laboratory reports, and imaging systems; quality monitor management ...
In 2010, Quintiles opens new European headquarters in the UK and establishes operations in East Africa. In 2011, Quintiles buys Advion Biosciences, a bioanalytical lab based out of Ithaca, New York. In 2013, Quintiles filed for an IPO on 15 February in order to go public again; Quintiles begins trading on the New York Stock Exchange (NYSE ...
As of 2019, twelve of top 20 biopharmaceutical companies in the world has U.S. headquarters in the state. [9] [10] Below is a list of notable New York metropolitan area biotechnology and pharmaceutical corporations, including companies with either global or U.S. headquarters in the metropolitan region encompassing and surrounding New York City.
New York & Company: retail New York Board of Trade: financial exchanges New York Life: insurance New York Mercantile Exchange: financial exchanges New York Private Bank & Trust: financial services New York Stock Exchange: financial exchanges The New York Times Company: media New Young Broadcasting: media Newmark Grubb Knight Frank: real estate
New York City, USA ... MD, PhD: Headquarters: New York City. Number of locations. United States: Area served. Worldwide: ... ViS was acquired by IQVIA (formerly known ...
IMS Health's corporate headquarters is located in Danbury, Connecticut, United States. The company's chairman and CEO is Ari Bousbib. In 1998, the parent company, Cognizant Corporation, split into two companies: IMS Health and Nielsen Media Research.
Fortrea Holdings Inc. is a contract research organization organized in Delaware and headquartered in Durham, North Carolina with operations in 90 countries. Its customers are primarily in the pharmaceutical, biotechnology, and medical device industries.
At the time, the real estate market in New York City was growing, and Equitable had projected that the building would generate $40 million in gross income by 1991. [172] In 1985, Tishman Speyer formed a limited partnership , 1515 Broadway Associates LP, to assume ownership of the building; the partnership's only asset was One Astor Plaza. [ 173 ]